Assessment of in vivo antimalarial activity of rifampicin, isoniazide, and ethambutol combination therapy

Parasitology Research

Volumn 106, Issue 6, 2010, Pages 1481-1484

  Aditya, Nayak P ^a   Patankar, Swati ^b   Madhusudhan, Basavaraj ^a  

^a KUVEMPU UNIVERSITY   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATININE; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; IN VIVO STUDY; MALARIA; MORTALITY; MOUSE; NONHUMAN; OVERALL SURVIVAL; PLASMODIUM BERGHEI; PRIORITY JOURNAL; TREATMENT OUTCOME; UREA BLOOD LEVEL;

ANIMALIA; MUS; PLASMODIUM BERGHEI;

EID: 77953325573     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-010-1789-y     Document Type: Article

References (8)

1. NE Alger DT Spira PH Silverman 1970 Inhibition of rodent malaria in mice by rifampicin Nature 227 381 382 10.1038/227381b0 1:CAS:528:DyaE3cXkvFOhtro%3D 5428437
2. D Butler 2004 Global fund changes track on malaria therapy Nature 429 588 10.1038/429588a 1:CAS:528:DC%2BD2cXks1Kmurg%3D 15190315
3. Genton B., Mueller I et al (2006) Rifampicin/Cotrimoxazole/Isoniazid versus mefloquine or quinine p sulfadoxine-pyrimethamine for malaria: A randomized trial. PLOS Clin Trial. doi: 10.1371/journal.pctr.0010038
4. H Jomaa J Wiesner 1999 Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs Science 285 1573 1576 10.1126/science.285.5433.1573 1:CAS:528:DyaK1MXlslOqsrY%3D 10477522 (Pubitemid 29420582)
5. AM Lenaerts SE Chase, et al. 2000 Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model Antimicrob Agents Chemother 44 3167 3168 10.1128/AAC.44.11.3167-3168.2000 1:CAS:528:DC%2BD3cXnvVSisLw%3D 11036043
6. MA Steele RF Burk RM DesPrez 1991 Toxic hepatitis with isoniazid and rifampin. A meta-analysis Chest 99 465 71 10.1378/chest.99.2.465 1:STN:280:DyaK3M7hsVCisA%3D%3D 1824929
7. M Strath FT Scott, et al. 1993 Antimalarial activity of rifampicin in vitro and in rodent models Trans R Soc Trop Med Hyg 87 211 216 10.1016/0035-9203(93)90497-E 1:STN:280:DyaK3szjtFGrtQ%3D%3D 8337732
8. RF Waller SA Ralph, et al. 2003 A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum Antimicrob Agents Chemother 47 297 301 10.1128/AAC.47.1.297-301.2003 1:CAS:528: DC%2BD3sXis12msA%3D%3D 12499205 (Pubitemid 36070378)